Tobacco: Science, Policy and Public Health Second Edition comprehensively covers the science and policy issues relevant to one of the major public health disasters of modern times. It pulls together the aetiology and burden of the myriad of tobacco-related diseases with the successes and failures of tobacco control policies. The book looks at lessons learnt to help set health policy for reducing the burden of tobacco-related diseases. It also deals with the international public health policy issues which bear on control of the problem of tobacco use and which vary between continents.

New chapters in this second edition include: Market manipulation: How the tobacco industry recruits and retains smokers; In Their Own Words: An Epoch of Deceit and Deception; Manipulating Product Design to Reinforce Tobacco Addiction; and a new section of the text devoted to 'Tobacco around the world'.

The editors are an international group distinguished in the field of tobacco-related diseases, epidemiology, and tobacco control. The contributors are world experts drawn from the various clinical fields. This major reference text gives a unique overview of one of the major public health problems in both the developed and developing world.

About the Author:
Nigel Gray graduated in Medicine in 1953 in Melbourne, Australia, and specialized in infectious disease and paediatrics until 1968 when he was appointed Director of the Anti-Cancer Council of Victoria. From 1974 to 1990 he chaired the Tobacco Program of the International Union Against Cancer (UICC). In 1987 he was the principal architect of the Victorian Tobacco Act, which provided for the first hypothecated tobacco tax, which was directed to the Victorian Health Promotion Foundation. Since 1995 he has worked internationally on Tobacco control, for eight years at the European Institute for Oncology in Milan and then at the International Agency for Research on cancer (IARC). During this time he has lectured extensively on the international scene with a particular interest in Tobacco Control policy and most recently on regulation of constituents and emissions of tobacco, both smoked and smokeless. He is currently a member of the WHO Study Group on Tobacco Regulation. Dr. Jack E.
Henningfield is a scientist trained in behavioural, pharmacological, and neurosciences, specializing in addictive drugs. He received his doctorate from the Psychopharmacology Training Program of the University of Minnesota in 1977. His research has spanned addictive drugs including alcohol, barbiturates, cocaine, marijuana, morphine and nicotine, including extensive research and applied work in the assessment and control of prescription drug abuse. Dr. Henningfield has been on faculty at The Johns Hopkins Medical School since 1978 and is affiliated as well with The Johns Hopkins Bloomberg School of Public Health. His current professional activities at the health policy consulting group, Pinney Associates in Bethesda, Maryland, focuses on the intersection of science, public health, and policy, as related to tobacco, prescription drugs, and illicit drugs of abuse. John Seffrin has been CEO of the American Cancer Society since 1992. He is a past president of the Geneva-headquartered
International Union Against Cancer, the first globally-oriented cancer non-governmental organization (NGO). He served as chairman of the board of Independent Sector, the largest coalition of nonprofit groups, and he helped to create the National Center for Tobacco-Free Kids (now the Campaign for Tobacco-Free Kids), among his many collaborations and affiliations. In 1999, Dr. Seffrin was selected to be a charter member of C-Change (formerly known as the National Dialogue on Cancer) Steering Committee. In 1997, he was appointed to the National Cancer Policy Board of the Institute of Medicine, and in 1999, he was appointed by Senator Dianne Feinstein to co-chair the National Cancer Legislation Advisory Committee. He current serves on the Advisory Committee to the Director of the US Centers for Disease Control and Prevention, a Secretary-level appointment. Dr Witold Zatonski is a Director and Professor in the Division of Epidemiology & Cancer Prevention Center & Institute of Oncology in
Warsaw, Poland. In the last 10 years Professor Zato?ski has been especially actively involved in work on health in Eastern Europe. Together with his team he has just finished challenging comprehensive research project HEM - Closing the Gap, analysing the health gap, and its causes, between eastern and western part of European Union. He has been at the forefront of public health and tobacco control in Poland, Eastern Europe, and internationally for more than 35 years. Though a passionate activist, Dr Zato?ski is also a meticulous researcher, and he has consistently backed his public health campaigns with scientific data. His approach has been effective, and many consider him to be single-handedly responsible for the over 30 percent decline in smoking in Poland over the last 25 years.